Related Articles
ASA404, a vascular disrupting agent, as an experimental treatment approach for brain tumors
Bortezomib induces apoptosis and suppresses cell growth and metastasis by inactivation of Stat3 signaling in chondrosarcoma
Molecular study on copper-mediated tumor proteasome inhibition and cell death
Bortezomib alleviates drug-induced liver injury by regulating CYP2E1 gene transcription
Differential sensitivity of breast cancer and melanoma cells to proteasome inhibitor Velcade